Per- and polyfluoroalkyl substances (PFAS) have been valued as a cheap and versatile compound utilized across global industries for decades, but the tide is turning. With studies linking exposure to severe health and environmental impacts, these “forever chemicals” now represent a regulatory and reputational challenge. This paper explores how investors can capture value amid this transition.